story of the week
Adding Abiraterone or Docetaxel to Long-Term Hormone Therapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
Adding Abiraterone or Docetaxel to Long-Term Hormone Therapy for Prostate Cancer: Directly Randomised Data From the STAMPEDE Multi-Arm, Multi-Stage Platform Protocol
Ann. Oncol 2018 Feb 26;[EPub Ahead of Print], MR Sydes, MR Spears, MD MasonAdvanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.